Searched for
GLAND PHARMA PROFIT
Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth promp...- Quant Small Cap Fund exits RIL, 8 others; raises exposure to two Adani stocks. Check full listQuant Small Cap Fund made a major portfolio reshuffle in June, exiting Reliance Industries and eight other stocks while increasing exposure...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities ended lower after four straight gains as profit booking, weak global cues and caution ahead of the US Fed minutes weighed o...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividendShares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its C...
- Gland Pharma Q2 Results: Profit rises 12% to Rs 184 croreGland Pharma on Monday reported 12 per cent year-on-year increase in profit after tax (PAT) at Rs 184 crore for the September quarter, aide...
- Gland Pharma Q4 Results: Net profit down 3% at Rs 186 croreGland Pharma Ltd on Tuesday reported a 3 per cent decline in consolidated net profit to Rs 186.54 crore in the fourth quarter ended March 3...
- Gland Pharma shares fall over 4% after weak Q3 result, Jefferies target price cutGland Pharma share price: Revenue from operations fell 10% year-on-year to Rs 1,384 crore. EBITDA increased by 1% year-on-year to Rs 360 cr...
- Gland Pharma Q3 net profit rises 7% to Rs 205 croreGland Pharma on Monday reported 7% year-on-year (YoY) rise in net profit to Rs 205 crores in Q3FY25.
- Gland Pharma shares zoom 12% post Q2 results; Kotak upgrades on limited downsideGland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to 'Reduce' with ...
- Gland Pharma shares hit 20% lower circuit after disappointing Q4 resultsGland Pharma's stock prices hit a 20% lower circuit on BSE after the firm reported a 72% YoY drop in net profit to Rs 79 crore in Q4FY23 du...
- Gland says not heard from its promoter Fosun about the potential saleThe debt-laden Chinese conglomerate Fosun controlled by billionaire entrepreneur Guo Guangchang has been looking to sell non-core assets, t...
- Gland Pharma slides further on weak Q2, stress at FosunThe pessimistic outlook by the rating agency triggered speculation that the Chinese firm may likely sell its stake in the Indian pharma com...
- 6 must-reads of ET Wealth: 6 stocks with up to 41% upside potential, why Gland Pharma is this week's stock pickA rundown of the six most important stories from Wealth this week. We tell you why analysts are bullish on Gland Pharma, 6 stocks with stro...
- Chinese-owned Gland Pharma re-appoints Srinivas Sadu as MD & CEOGland Pharma reported revenues of Rs 3463 and a net profit of Rs 997 crore in FY21. Shares of Gland Pharma rose 1.89% to close at Rs 3360 o...
- Smartkarma Research: APAC Healthcare Series - Top picks are poised for multi-year growthGland Pharma’s near-term focus remains on establishing a strong portfolio of complex injectables. The company is working on development of ...
- Gland Pharma shares rally nearly 8%; at 52-week high after Q1 earningsDrug firm Gland Pharma on Wednesday reported an 11.83 per cent increase in its consolidated net profit to Rs 350.7 crore for the quarter en...
- Gland Pharma Q1 results: Net profit rises 12% to Rs 351 crConsolidated revenue from operations of the company stood at Rs 1,153.9 crore for the quarter under consideration. It was Rs 884.2 crore fo...
- Buy Gland Pharma, target price Rs 2900: Motilal OswalMotilal Oswal has a buy call on Gland Pharma with a target price of Rs 2900. The current market price of Gland Pharma is Rs 2652.95.
- Buy Gland Pharma, target price Rs 2700: Motilal OswalGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 37108.47 Crore) operating in Pharmaceut...
Load More
